Navigation Links
Camp High Harbour Response to Flu Outbreak Includes SpectraSan 24 Disinfectant
Date:7/16/2009

EPA-Registered, SpectraSan 24 Kills Influenza A Viruses, MRSA, Staph and Host of Other Micro-Organisms on Hard Surfaces for Infection Control, Recommended for use in Childcare Environments.

North Canton, OH (PRWEB) July 16, 2009 -- In mid-June, almost one third of the weekly campers at YMCA Camp High Harbour in Clayton, Georgia left early because of signs of H1N1 Swine flu-like symptoms or parental fears. A representative of BioTech Medical LLC heard about the summer camp's situation and was confident that his company's newly launched product - SpectraSan 24 - would help curtail the spread of illness.

On June 20, ten donated cases of SpectraSan 24 arrived and the camp's maintenance staff was met by the BioTech Medical representative who explained in detail the differences between "cleaning and disinfecting."

The next day, the camp opened its doors to the new, weekly session of campers. The SpectraSan 24 daily disinfectant became one major component of several changes instituted at the camp to help keep the number of sick campers to a minimum. The four-fold response included environmental cleaning, respiratory and hand hygiene, active camper screening and pro-active communication.

Shortly thereafter, BioTech Medical received the following email:

"We are halfway through the week, and no one has come to the infirmary with flu-like symptoms. In fact, we would like to purchase additional product for continuous disinfecting throughout the summer. We have sprayed the cabins, boats, life jackets, serving counters, buses and all meeting areas such as the dining hall, amphitheater and chapel. I believe this may have been a blessing. Your product has helped us with the Type A Influenza and with other viruses that commonly attack us every year such as strep throat, pink eye, etc. This has been a life-changer. Please feel free to share my name for any other camp directors inquiring about the product." -- Ken O'Kelley, Executive Director

"The EPA believes, based on available scientific information, that the currently registered Influenza A virus products will be effective against the 2009 H1N1 Flu Strain on hard, non-porous surfaces," stated Andrea Goren, executive director of North Canton, Ohio-based BioTech Medical. "However, only SpectraSan 24 has 24-hour residual efficacy and kills germs 20 times faster than traditional disinfectants on the market. It has the lowest toxicity rating assigned by the EPA, is non-corrosive, non-flammable, and is recommended for use in child care environments. It is EPA-registered and the first patented disinfectant in over 30 years."

"BioTech Medical is offering up to a 35% savings on any purchases of SpectraSan 24 through August 31, 2009," Goren added. "We are committed to helping adults and children across the country experience a happy and healthy summer."

To order product, or for additional information:
Andrea L. Goren
BioTech Medical LLC
phone: 800.284.9857 x 4260

About SpectraSan 24:
SpectraSan 24 is a new innovative broad-spectrum disinfectant (bactericidal, virucidal, and fungicidal) with 24-hour residual protection. SpectraSan 24 uses the advanced patented technology of SDC (Silver Dihydrogen Citrate) to kill 99.999% of germs more quickly and effectively than any other product on the market, while currently being the only registered disinfectant assigned the lowest toxicity rating (IV) by the EPA.

SpectraSan 24 is intended for use on hard non-porous surfaces in hospitals, nursing homes, correctional facilities, healthcare facilities, universities, grammar schools, middle schools, daycare centers, athletic facilities, community centers, office environments, cruise ships, airports, buses, metro liners, and other public places.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2646124.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Spectacular Ultra-Luxe Auction for Destination Fashion 2009, Presented by Stewart Rahr, Best of Bal Harbours Brands Contribute More Than $250,000 Worth of Exclusive Items
2. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
3. Study identifies key player in the bodys immune response to chronic stress
4. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
5. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
6. Merck & Co., Inc. Response to Todays New York Medicaid Suit
7. Maternal depression and controlling behavior associated with increased stress response in infants
8. Family history of alcoholism affects response to drug used to treat heavy drinking
9. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
10. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
11. PET scans can accurately detect a breast tumors response to chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Camp High Harbour Response to Flu Outbreak Includes SpectraSan 24 Disinfectant
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... women on Friday in recognition of National Wear Red Day. National Wear Red ... heart disease and stroke in women. Heart disease and stroke cause 1 in 3 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 2016 , ... US Sports Camps is proud to sponsor the Bay Area ... top non-profit leaders, ultimate organizations, and coaches from around the US. The theme for ... Program Director of Youth and Education, describes this year YUCC as “an important conversation ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
Breaking Medicine Technology: